| Dr Jerry A Cohen, DO | |
|
857 Montgomery Ave, Narberth, PA 19072-1541 | |
| (610) 664-2951 | |
| (610) 664-2131 |
| Full Name | Dr Jerry A Cohen |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 50 Years |
| Location | 857 Montgomery Ave, Narberth, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629015680 | NPI | - | NPPES |
| 0006617510002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | OS003273L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Continuous Home Care Inc | Havertown, PA | Home health agency |
| Serenity Hospice | Bensalem, PA | Hospice |
| Keystone Hospice | Wyndmoor, PA | Hospice |
| Compassionate Care Hospice | Bensalem, PA | Hospice |
| Compassus - Greater Philadelphia | Fort washington, PA | Hospice |
| Albert Einstein Medical Center | Philadelphia, PA | Hospital |
| Cheltenham Nursing And Rehab C | Philadelphia, PA | Nursing home |
| Cliveden Nursing And Rehabilitation Center | Philadelphia, PA | Nursing home |
| Bala Nursing And Retirement Ce | Philadelphia, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Medical Group Ltd | 9830003599 | 9 |
News Archive
Adding denosumab to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal patients with early-stage, hormone receptor (HR)-positive breast cancer, according to results from the phase III ABCSG-18 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.
Diagenode announced today that it has released two additional 5-hmC antibodies to complement its original 5-hmC (rat) monoclonal antibody. The two new 5-hmC monoclonal antibody (mouse) and polyclonal antibody (rabbit) antibodies give researchers additional choices for enriching and analyzing 5-hmC in their methylation studies.
Clermont Pharmaceuticals, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today positive results from a phase III trial of non-preserved latanoprost. In the study, non-preserved latanoprost was compared to Xalatan (latanoprost ophthalmic solution) 0.005%, in subjects diagnosed with open-angle glaucoma.
A team of researchers in France, led by Dr. Ana Buj-Bello (Genethon/Inserm) and teams at the University of Washington and Harvard Medical School in the United States, achieved a new step towards the treatment of myotubular myopathy by gene therapy.
› Verified 3 days ago
| Entity Name | Main Line Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760415913 PECOS PAC ID: 9830003599 Enrollment ID: O20031117000677 |
News Archive
Adding denosumab to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal patients with early-stage, hormone receptor (HR)-positive breast cancer, according to results from the phase III ABCSG-18 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.
Diagenode announced today that it has released two additional 5-hmC antibodies to complement its original 5-hmC (rat) monoclonal antibody. The two new 5-hmC monoclonal antibody (mouse) and polyclonal antibody (rabbit) antibodies give researchers additional choices for enriching and analyzing 5-hmC in their methylation studies.
Clermont Pharmaceuticals, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today positive results from a phase III trial of non-preserved latanoprost. In the study, non-preserved latanoprost was compared to Xalatan (latanoprost ophthalmic solution) 0.005%, in subjects diagnosed with open-angle glaucoma.
A team of researchers in France, led by Dr. Ana Buj-Bello (Genethon/Inserm) and teams at the University of Washington and Harvard Medical School in the United States, achieved a new step towards the treatment of myotubular myopathy by gene therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerry A Cohen, DO 857 Montgomery Ave, Narberth, PA 19072-1541 Ph: (610) 664-2951 | Dr Jerry A Cohen, DO 857 Montgomery Ave, Narberth, PA 19072-1541 Ph: (610) 664-2951 |
News Archive
Adding denosumab to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal patients with early-stage, hormone receptor (HR)-positive breast cancer, according to results from the phase III ABCSG-18 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.
Diagenode announced today that it has released two additional 5-hmC antibodies to complement its original 5-hmC (rat) monoclonal antibody. The two new 5-hmC monoclonal antibody (mouse) and polyclonal antibody (rabbit) antibodies give researchers additional choices for enriching and analyzing 5-hmC in their methylation studies.
Clermont Pharmaceuticals, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today positive results from a phase III trial of non-preserved latanoprost. In the study, non-preserved latanoprost was compared to Xalatan (latanoprost ophthalmic solution) 0.005%, in subjects diagnosed with open-angle glaucoma.
A team of researchers in France, led by Dr. Ana Buj-Bello (Genethon/Inserm) and teams at the University of Washington and Harvard Medical School in the United States, achieved a new step towards the treatment of myotubular myopathy by gene therapy.
› Verified 3 days ago
Margaret Steane Lytton, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 145 N Narberth Ave, Narberth, PA 19072 Phone: 610-667-0650 Fax: 610-667-1481 | |
Andrew Mark Lipton, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 822 Montgomery Ave, Suite 315, Narberth, PA 19072 Phone: 610-667-4601 Fax: 610-667-6416 | |
Dr. Rosemarie Monzo, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 857 Montgomery Avenue, Main Line Medical Group, Narberth, PA 19072 Phone: 610-664-2951 Fax: 610-664-2131 | |
Dr. Jerome Miller, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 216 Tower Ln, Narberth, PA 19072 Phone: 610-667-6889 Fax: 610-667-0630 | |
Dr. Ritu Aggarwal, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 N Narberth Ave Fl 1, Narberth, PA 19072 Phone: 610-667-0650 Fax: 610-667-1481 | |
Todd Alan Hoover, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 822 Montgomery Ave, Suite 306, Narberth, PA 19072 Phone: 610-667-2138 Fax: 610-667-2139 | |
Dr. Steven Craig Lewis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 857 Montgomery Ave, Narberth, PA 19072 Phone: 610-664-2951 Fax: 610-664-2131 |